Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 4 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.
Cancer Res. 2022 Dec 16;82(24):4586-4603. doi: 10.1158/0008-5472.CAN-22-2108.
Cancer Res. 2022.
PMID: 36219398
Free PMC article.
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.
Goddard J, Castle J, Southworth E, Fletcher A, Crosier S, Martin-Guerrero I, García-Ariza M, Navajas A, Masliah-Planchon J, Bourdeaut F, Dufour C, Ayrault O, Goschzik T, Pietsch T, Sill M, Pfister SM, Rutkowski S, Richardson S, Hill RM, Williamson D, Bailey S, Schwalbe EC, Clifford SC, Hicks D.
Goddard J, et al.
Acta Neuropathol. 2023 May;145(5):651-666. doi: 10.1007/s00401-023-02566-0. Epub 2023 Apr 4.
Acta Neuropathol. 2023.
PMID: 37014508
Free PMC article.
Item in Clipboard
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment.
Hill RM, Plasschaert SLA, Timmermann B, Dufour C, Aquilina K, Avula S, Donovan L, Lequin M, Pietsch T, Thomale U, Tippelt S, Wesseling P, Rutkowski S, Clifford SC, Pfister SM, Bailey S, Fleischhack G.
Hill RM, et al.
Cancers (Basel). 2021 Dec 28;14(1):126. doi: 10.3390/cancers14010126.
Cancers (Basel). 2021.
PMID: 35008290
Free PMC article.
Review.
Item in Clipboard
ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors.
Mainwaring OJ, Weishaupt H, Zhao M, Rosén G, Borgenvik A, Breinschmid L, Verbaan AD, Richardson S, Thompson D, Clifford SC, Hill RM, Annusver K, Sundström A, Holmberg KO, Kasper M, Hutter S, Swartling FJ.
Mainwaring OJ, et al.
Nat Commun. 2023 Mar 3;14(1):1221. doi: 10.1038/s41467-023-36847-9.
Nat Commun. 2023.
PMID: 36869047
Free PMC article.
Item in Clipboard
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse.
Richardson S, Hill RM, Kui C, Lindsey JC, Grabovksa Y, Keeling C, Pease L, Bashton M, Crosier S, Vinci M, André N, Figarella-Branger D, Hansford JR, Lastowska M, Zakrzewski K, Jorgensen M, Pickles JC, Taylor MD, Pfister SM, Wharton SB, Pizer B, Michalski A, Joshi A, Jacques TS, Hicks D, Schwalbe EC, Williamson D, Ramaswamy V, Bailey S, Clifford SC.
Richardson S, et al.
Neuro Oncol. 2022 Jan 5;24(1):153-165. doi: 10.1093/neuonc/noab178.
Neuro Oncol. 2022.
PMID: 34272868
Free PMC article.
Item in Clipboard
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development.
Danilenko M, Zaka M, Keeling C, Crosier S, Lyman S, Finetti M, Williamson D, Hussain R, Coxhead J, Zhou P, Hill RM, Hicks D, Rand V, Joshi A, Schwalbe EC, Bailey S, Clifford SC.
Danilenko M, et al.
Acta Neuropathol. 2022 Sep;144(3):565-578. doi: 10.1007/s00401-022-02464-x. Epub 2022 Jul 13.
Acta Neuropathol. 2022.
PMID: 35831448
Free PMC article.
Item in Clipboard
Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development.
Williamson D, Schwalbe EC, Hicks D, Aldinger KA, Lindsey JC, Crosier S, Richardson S, Goddard J, Hill RM, Castle J, Grabovska Y, Hacking J, Pizer B, Wharton SB, Jacques TS, Joshi A, Bailey S, Clifford SC.
Williamson D, et al.
Cell Rep. 2022 Aug 2;40(5):111162. doi: 10.1016/j.celrep.2022.111162.
Cell Rep. 2022.
PMID: 35926460
Free PMC article.
Item in Clipboard
Cite
Cite